The presence of BSA around the blot was confirmed by Ponceau S staining (not shown). confirming that TLR9 travels through the Golgi complex to access CpG DNA in endolysosomes. Together, Tipifarnib S enantiomer these data support a model where TLR9 uses Tipifarnib S enantiomer traditional secretory pathways and does not bypass the Golgi complex. Keywords:Brefeldin A, CpG DNA, Endolysosome, Golgi, TLR9, trafficking == INTRODUCTION == Toll-like receptors (TLRs) are innate Tipifarnib S enantiomer immune receptors important for host defense against pathogens1. While many TLRs are present at the cell surface, those dedicated to recognition of various nucleic acid structures are retained in intracellular compartments. Nucleic acid structures recognized by TLRs include dsRNA by TLR32, single-stranded RNA by TLR7 and 83and CpG DNA by TLR94,5. Notably, these structures are also present in self nucleic acids. Recognition of DNA by TLR9 occurs in endolysosomes, but TLR9 resides predominantly in the endoplasmic reticulum (ER) in resting cells59. Endolysosomal localization is usually important for TLR9 response to CpG DNA since TLR9 binds some DNA preferentially at low pH, endosomal acidification inhibitors block TLR9 signaling and TLR9 undergoes a conformational change upon CpG DNA binding in endolysosomes1012. CpG DNAs with different sequence and secondary structure can elicit either production of type I Interferon (IFN-) or maturation of plasmacytoid dendritic cells (pDCs) depending on the precise location of conversation with TLR9. Those CpG DNAs that induce IFN- production accumulate in early endosomes while those that induce maturation accumulate in lysosomes13. The mechanism regulating TLR9 translocation from the ER to these different compartments remains unclear. Intracellular localization of TLRs 3, 7, 8 and 9 may be a key factor to prevent recognition of self nucleic acids. Self nucleic acids are poorly endocytosed and rapidly degraded in the extra-cellular milieu. However, self DNA is recognized by TLR9 when it is presented by chromatin specific autoantibodies or the microbial peptide LL37, or when TLR9 is usually inappropriately localized. The inappropriate activation of TLR9 by self DNA results in the onset of a severe inflammatory response1416. Therefore, it is critical to uncover the mechanisms regulating TLR9 localization and trafficking. Since recent studies have proposed that TLR9 bypasses the Golgi complex during translocation from the ER to early endosomes7,17, we investigated the importance of Golgi export in TLR9 movement using newly developed assays and traditional biochemical methods. Our results show that a pool of TLR9 constitutively traffics from the ER through the Golgi complex and resides Tipifarnib S enantiomer in endolysosomes and that this pool of TLR9 is likely to be involved in signaling. Furthermore, transit of TLR9 through the Golgi complex occurs in response to CpG DNA and is required for optimal signaling. These data shed new light around the pathways of TLR9 movement within the cell. Control of TLR9 movement along these pathways likely regulates discrimination between self and non-self DNA. == RESULTS == Rabbit Polyclonal to Caspase 7 (Cleaved-Asp198) == TLR9 signaling requires Golgi transport == The observation that TLR9 remains sensitive to digestion with endoglycosidase H (EndoH) following CpG DNA stimulation7(Supplementary Physique 1) has led to a model where TLR9 bypasses the Golgi complex when it translocates from the ER to endolysosomes. However, sensitivity to EndoH digestion is not a definitive marker for ER localization18. EndoH digests both high mannose glycans (found on proteins in the ER) and hybrid glycan modifications (found on proteins Tipifarnib S enantiomer in the Golgi complex). To directly test if TLR9 bypasses the Golgi complex, we blocked Golgi export using the fungal metabolite Brefeldin A (BFA). BFA blocks Golgi export by preventing ADP ribosylation factor (ARF) association with the Golgi membrane and the formation of the coatamer complex1921. Pre-treatment with BFA significantly inhibited TLR9-induced NF-B activation in a dose dependent manner (Physique 1a). The inhibitory effect of BFA was significant with 15 minutes pre-treatment, an effect that was slightly greater with longer pre-treatment (Physique 1b). Some TLRs, such as TLR2, TLR4 and TLR5 constitutively traffic to and signal from the cell surface6,9,2225. These TLRs should not be inhibited by BFA since they do not depend on Golgi export to initiate signal transduction. TLR5 signaling was not inhibited by pretreatment with BFA, supporting the conclusion that this inhibitory effect on TLR9 signaling was not due to toxic effects (Physique 1a and 1b). Incubation of a human B cell line with fluorescently labeled CpG DNA resulted in binding and endocytosis as measured by an increase in mean fluorescence intensity (MFI) (3.9 with no CpG DNA, binding: 24.3 with labeled CpG DNA at.